Literature DB >> 35019039

The potential impact of COVID-19 and diabetes on intervertebral disc degeneration.

Luciano Rodrigo Lopes1, Silvana Kertzer Kasinski1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35019039      PMCID： PMC8687644          DOI： 10.31744/einstein_journal/2021CE6911

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN： 1679-4508


× No keyword cloud information.
  5 in total

Review 1.  Diabetes mellitus as a risk factor for intervertebral disc degeneration: a critical review.

Authors:  Kalliopi Alpantaki; Alkisti Kampouroglou; Christos Koutserimpas; Grigoris Effraimidis; Alexander Hadjipavlou
Journal:  Eur Spine J       Date:  2019-06-14       Impact factor: 3.134

2.  Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells.

Authors:  Yu Song; Yan Wang; Yukun Zhang; Wen Geng; Wei Liu; Yong Gao; Shuai Li; Kun Wang; Xinghuo Wu; Liang Kang; Cao Yang
Journal:  J Cell Mol Med       Date:  2017-02-22       Impact factor: 5.310

Review 3.  A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic.

Authors:  Chris R Triggle; Devendra Bansal; Hong Ding; Md Mazharul Islam; Elmoubashar Abu Baker Abd Farag; Hamad Abdel Hadi; Ali A Sultan
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 4.  COVID-19 and diabetes mellitus: from pathophysiology to clinical management.

Authors:  Soo Lim; Jae Hyun Bae; Hyuk-Sang Kwon; Michael A Nauck
Journal:  Nat Rev Endocrinol       Date:  2020-11-13       Impact factor: 47.564

5.  The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis.

Authors:  Juan Chen; Chunhua Wu; Xiaohang Wang; Jiangyi Yu; Zilin Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-05       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.